PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹4,529 Cr | ₹3,393 Cr | ₹2,645 Cr | ₹3,812 Cr | ₹2,903 Cr |
What is the latest Total Non-Current Liabilities ratio of PIRAMAL PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹4,529 Cr |
| Mar2025 | ₹3,393 Cr |
| Mar2024 | ₹2,645 Cr |
| Mar2023 | ₹3,812 Cr |
| Mar2022 | ₹2,903 Cr |
How is Total Non-Current Liabilities of PIRAMAL PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,529 Cr | 33.50 | |
| Mar2025 | ₹3,393 Cr | 28.29 | |
| Mar2024 | ₹2,645 Cr | -30.62 | |
| Mar2023 | ₹3,812 Cr | 31.33 | |
| Mar2022 | ₹2,903 Cr | - | |
Compare Total Non-Current Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹28,443.2 Cr | -0.6% | 5.6% | 14.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -0.6% |
5.6% |
14.4% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses